Alexander J Denner Insider Trading $BIVV Bioverativ Inc.
Get free email notifications about insider trading for Alexander J Denner.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Alexander J Denner. Alexander J Denner is Director in ARIAD PHARMACEUTICALS INC ($ARIA) and Director in BIOGEN INC. ($IDPH) and Director in VIVUS INC ($VVUS) and 10% Owner in APRICUS BIOSCIENCES, INC. ($APRI) and Director in MEDICINES CO /DE ($MDCO) and Director in IRONWOOD PHARMACEUTICALS INC ($IRWD) and 10% Owner in Regulus Therapeutics Inc. ($RGLS) and 10% Owner in Iterum Therapeutics plc ($ITRM) and Director in Bioverativ Inc. ($BIVV).
Alexander J Denner in Bioverativ Inc.
Trading Symbol: BIVVIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Alexander J Denner: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Mar 08 2018
$BIVV Market Capitalization: $4637.62B
$BIVV Previous Close: $44.44
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Alexander J Denner in Bioverativ Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ARIA, IDPH, BIVV, IRWD, ITRM, MDCO, RGLS, SEEL, VVUS
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 08 2018 | BIVV | Bioverativ Inc. | DENNER ALEXANDER J | Director | Option Exercise | D | 44.51 | 26,818 | 1,193,669 | 0 | |
Mar 08 2018 | BIVV | Bioverativ Inc. | DENNER ALEXANDER J | Director | Option Exercise | D | 0.00 | 5,455 | 0 | 0 | |
Mar 08 2018 | BIVV | Bioverativ Inc. | DENNER ALEXANDER J | Director | Sell | D | 0.00 | 1,165,000 | 0 | 0 | 1.2 M to 0 (-100.00 %) |
Mar 08 2018 | BIVV | Bioverativ Inc. | DENNER ALEXANDER J | Director | Sell | D | 0.00 | 5,001 | 0 | 0 | 5 K to 0 (-100.00 %) |
Feb 02 2018 | BIVV | Bioverativ Inc. | DENNER ALEXANDER J | Director | Option Exercise | A | 0.00 | 5,455 | 0 | 5,455 | |
Aug 31 2017 | BIVV | Bioverativ Inc. | DENNER ALEXANDER J | Director | Grant | A | 56.69 | 932 | 52,835 | 1,165,000 | 1.2 M to 1.2 M (+0.08 %) |
Jun 01 2017 | BIVV | Bioverativ Inc. | DENNER ALEXANDER J | Director | Buy | P | 55.93 | 90,000 | 5,033,475 | 1,165,000 | 1.1 M to 1.2 M (+8.37 %) |
May 26 2017 | BIVV | Bioverativ Inc. | DENNER ALEXANDER J | Director | Buy | P | 57.21 | 450,000 | 25,745,130 | 1,075,000 | 625 K to 1.1 M (+72.00 %) |
May 26 2017 | BIVV | Bioverativ Inc. | DENNER ALEXANDER J | Director | Buy | P | 54.98 | 130,000 | 7,147,907 | 625,000 | 495 K to 625 K (+26.26 %) |
May 26 2017 | BIVV | Bioverativ Inc. | DENNER ALEXANDER J | Director | Buy | P | 54.16 | 340,000 | 18,414,400 | 495,000 | 155 K to 495 K (+219.35 %) |
Apr 17 2017 | BIVV | Bioverativ Inc. | DENNER ALEXANDER J | Director | Grant | A | 56.83 | 1,056 | 60,012 | 5,001 | 3.9 K to 5 K (+26.77 %) |
Feb 16 2017 | BIVV | Bioverativ Inc. | DENNER ALEXANDER J | Director | Option Exercise | A | 44.51 | 26,770 | 1,191,533 | 26,770 | |
Feb 16 2017 | BIVV | Bioverativ Inc. | DENNER ALEXANDER J | Director | Option Exercise | A | 44.51 | 26,770 | 1,191,533 | 26,770 |
Page: 1